[使用Relatox (甲型玻尿素毒素) 治疗慢性偏头痛的经验]
Yu E Azimova1,2, K V Skorobogatykh1, D Z Korobkova1
1LLC University Clinic, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|January 12, 2026
概括
毒素A型注射 (Relatox) 在现实环境中有效减少了慢性偏头痛的日子. 这种治疗方法在每12周一次使用时显示出良好的安全性和累积益处.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性偏头痛是一种衰弱的神经疾病.
- 毒素A型注射是一种潜在的治疗选择.
研究的目的:
- 评估常规实践中治疗慢性偏头痛的Relatox的疗效,安全性和临床特征.
- 在专门的头痛中心评估Relatox治疗结果.
主要方法:
- 一项对150名慢性偏头痛患者进行的开放式回顾性研究.
- 使用PREEMPT或"跟随疼痛"协议,每12周服用155-195个单位的Relatox.
- 包括对其他偏头痛预防药物耐药的患者.
主要成果:
- 在12周后,偏头痛日数显著减少,从24.4日减少到14.3日 (p<0.001).
- 61.3%的患者实现了偏头痛日减少≥30%.
- 不良事件很少发生 (3.3%),包括轻微的困难和亡.
结论:
- 在现实世界的临床实践中,Relatox在治疗慢性偏头痛方面是有效和安全的.
- 观察到的累积治疗效果与一致的12周服用间隔.
- 支持在专门的头痛中心使用Relatox来治疗慢性偏头痛.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
878
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
878
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.5K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.5K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K


